Slate Path Capital Lp - Net Worth and Insider Trading
Slate Path Capital Lp Net Worth
The estimated net worth of Slate Path Capital Lp is at least $0 dollars as of 2024-11-29. Slate Path Capital Lp is the 10% Owner of Cyclerion Therapeutics Inc and owns about 0 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $0. Details can be seen in Slate Path Capital Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Slate Path Capital Lp has not made any transactions after 2024-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Slate Path Capital Lp
Slate Path Capital Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Slate Path Capital Lp owns 1 companies in total, including Cyclerion Therapeutics Inc (CYCN) .
Click here to see the complete history of Slate Path Capital Lp’s form 4 insider trades.
Insider Ownership Summary of Slate Path Capital Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2024-11-21 | 10 percent owner |
Slate Path Capital Lp Latest Holdings Summary
Slate Path Capital Lp currently owns a total of 1 stock. Slate Path Capital Lp owns 0 shares of Cyclerion Therapeutics Inc (CYCN) as of November 21, 2024, with a value of $0.
Latest Holdings of Slate Path Capital Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2024-11-21 | 0 | 2.16 | 0 |
Holding Weightings of Slate Path Capital Lp
Slate Path Capital Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Slate Path Capital Lp has made a total of 2 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Cyclerion Therapeutics Inc is the sale of 357,880 shares on November 21, 2024, which brought Slate Path Capital Lp around $554,714.
Insider Trading History of Slate Path Capital Lp
- 1
Slate Path Capital Lp Trading Performance
GuruFocus tracks the stock performance after each of Slate Path Capital Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Slate Path Capital Lp is -2.48%. GuruFocus also compares Slate Path Capital Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Slate Path Capital Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Slate Path Capital Lp's insider trading performs compared to the benchmark.
Performance of Slate Path Capital Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.36 | | | | | |
| Relative Return to S&P 500(%) | 17.56 | | | | | |
Slate Path Capital Lp Ownership Network
Slate Path Capital Lp Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Slate Path Capital Lp is the 10 percent owner of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , director & Chief Executive Officer Peter M Hecht , and Chief Financial Officer Anjeza Gjino .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
Over the past 18 months, Slate Path Capital Lp made 1 insider transaction in Cyclerion Therapeutics Inc (CYCN) with a net sale of 357,880. Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,
In summary, during the past 3 months, insiders sold 357,880 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 357,880 shares. During the past 18 months, 357,888 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 357,888 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Slate Path Capital Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Slate Path Capital Lp. You might contact Slate Path Capital Lp via mailing address: 717 5th Avenue, 16th Fl., New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
